Skip to contentLirea is launching soon. Join the waitlist to be notified.

GLP-1 medication tracker

In Phase 3 trials

Survodutide tracker

Your survodutide, on your device: your weekly dose and your trend.

Survodutide is a next-generation weekly injectable (a GLP-1 and glucagon agonist) in late-stage trials for weight management and fatty-liver disease. Whether you're in a trial or tracking it yourself, Lirea keeps a private, accurate record, kept on your phone, with no account.

One email on launch day, and nothing else. The app itself never asks for one.

Today

Your shot day

This week

Survodutide

weekly shot

Logged

Weight check-in

trend
Log a dose

What you'll track

Made for how you actually take Survodutide.

A once-weekly injection (in clinical trials).

Never miss your weekly dose

Pick your day, get a reminder before it's due, and log in one tap.

Follow your dose as it steps up

Survodutide is taken at increasing doses, often paused or slowed for tolerability. Lirea shows which step you're on and lets you hold a level.

Weight and how you feel

Track your weight as a trend and log side effects against your dose timing, the pattern is yours to see, privately.

One private place

Everything stays encrypted on your phone, with no account and no server.

Why Lirea

Your Survodutide data is nobody's business but yours.

No employer, insurer, or wellness platform ever sees what you log, and neither do we. It's stored and encrypted on your device, with no account and no server in the middle.

How your data stays yours
  • No account

    Open the app and start. We never ask who you are.

  • On-device

    Your data is stored and encrypted on your phone.

  • No analytics SDKs

    No Firebase, no trackers, no ad networks.

  • Check it yourself

    Turn on airplane mode. Everything but the paywall still works, because there is nothing on the other end.

Questions

Survodutide, tracked privately

Is survodutide FDA-approved or available?

Not yet. As of 2026 survodutide is in Phase 3 trials and is not FDA-approved. Lirea does not sell or supply it, it's a private tracker.

What makes survodutide different?

Its glucagon action draws extra interest for liver fat alongside weight loss. It's still under study, so we don't make outcome claims.

Is my data private?

Yes. Your dose log, weight, and side effects are stored and encrypted on your device, no account, no server.

Related trackers

Lirea is a private tracking tool, not a medical device, a pharmacy, or a source of medical advice. Anything shown here is general reference, not a recommendation. Always follow the guidance of a qualified healthcare provider.

Launching soon

Keep it, and keep it yours.

Track your weekly dose, your titration, and how you’re feeling, all on your device. No account required. Be first to know when Lirea is live.

One email at launch. No spam, unsubscribe anytime. This list is separate from the app, and we never receive your health data. Privacy.

App Store, soonGoogle Play, soon